ABBV AbbVie
$266.69 +0.35%
US Stock · Healthcare
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.35%
YTD
+14.50%
P/E
72.79
P/B
94.44
ROE
95.6%
Div yield
4.5%
Beta
-0.11
Market cap
$459.3B
RSI (14)
60
Next earnings
Oct 30, 2026
Previous session
close of Oct 6, 2026 · EOD, no live order bookOpen
$267.74
Close
$266.69
VWAP (n/a)
—
Day high
$268.70
Day low
$260.62
Volume
4.5M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
AbbVie (ABBV) Pays Out More Than It Earns. How Long Can That Hold?
Yahoo Finance · Oct 7
Forget Bonds: How Retirees Collect $6,650 a Month From Dividends Alone
Yahoo Finance · Oct 6
HSBC Thinks AbbVie Can Climb to $315. Here's the Bull Case in Plain English.
Yahoo Finance · Oct 6
Dual-acting drug from AbbVie, Genmab scores in frontline lymphoma trial
Yahoo Finance · Oct 6
Parkinson's Disease Market Poised for Expansion During the Forecast Period (2026-2036) Amid JUVMO Approval and Emerging Therapeutic Innovations | DelveInsight
Yahoo Finance · Oct 6
AbbVie's Epcoritamab Combo Shows PFS Benefit in Frontline DLBCL
Yahoo Finance · Oct 6
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
8-K Oct 5, 2026 View → 8-K Sep 3, 2026 View → 8-K Aug 18, 2026 View → 8-K Aug 5, 2026 View → 10-Q Aug 3, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell ABBV. Try it in the Lab to size a position and see the risk.